Cargando…

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications

Introduction: There is an urgent need for health authorities across Europe to fully realize potential savings from increased use of generics to sustain their healthcare systems. A variety of strategies were used across Europe following the availability of generic losartan, the first angiotensin rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, James C., Godman, Brian, Petzold, Max, Alvarez-Madrazo, Samantha, Bennett, Kathleen, Bishop, Iain, Bucsics, Anna, Hesse, Ulrik, Martin, Andrew, Simoens, Steven, Zara, Corinne, Malmström, Rickard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189327/ https://www.ncbi.nlm.nih.gov/pubmed/25339902 http://dx.doi.org/10.3389/fphar.2014.00219

Ejemplares similares

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications
por: Godman, Brian, et al.
Publicado: (2014)

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
por: Godman, Brian, et al.
Publicado: (2010)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
por: Godman, Brian, et al.
Publicado: (2014)

How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
por: Dylst, Pieter, et al.
Publicado: (2012)

Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
por: Godman, Brian, et al.
Publicado: (2011)

New pricing models for generic medicines to ensure long-term sustainable competition in Europe
por: Francois, Clement, et al.
Publicado: (2023)

Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future
por: Godman, Brian, et al.
Publicado: (2013)

The Portuguese generic medicines market: a policy analysis
por: Simoens, Steven
Publicado: (2009)

CHA2DS2-VASc Calculations in Patients with Atrial Fibrillation receiving oral anticoagulants in Scotland: an analysis of linked administrative data
por: Zeng, Wenjie, et al.
Publicado: (2017)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System
por: Eriksson, Irene, et al.
Publicado: (2018)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
por: Spillane, Susan, et al.
Publicado: (2015)

Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years
por: Andersson, Karolina A, et al.
Publicado: (2008)

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future
por: de Bruijn, Winnie, et al.
Publicado: (2016)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
por: Godman, Brian, et al.
Publicado: (2014)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

A Case Report of Losartan Induced Angioedema
por: Vedantam, Venkata, et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Losartan-Induced Angioedema: A Case Report
por: Mann, Henry, et al.
Publicado: (2023)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020)

IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation
por: Mansour, Randa S. H., et al.
Publicado: (2023)

Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study
por: Tian, Yuxi, et al.
Publicado: (2020)

Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2016)

Simultaneous determination of losartan, losartan acid and amlodipine in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
por: Karra, Vijaya Kumari, et al.
Publicado: (2012)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2017)

Generic coarse geometry of leaves
por: Álvarez López, Jesús A, et al.
Publicado: (2018)

Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
por: Kjeldsen, Sverre E, et al.
Publicado: (2007)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a8s463arddd1i8hhps2t4ai3ht